{"id":10256,"date":"2021-08-26T12:00:00","date_gmt":"2021-08-26T17:00:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/news\/shockwave-medical-to-participate-in-two-upcoming-virtual-investor-conferences\/"},"modified":"2021-08-26T12:00:00","modified_gmt":"2021-08-26T17:00:00","slug":"shockwave-medical-to-participate-in-two-upcoming-virtual-investor-conferences","status":"publish","type":"news","link":"https:\/\/shockwavemedical.com\/de\/news\/shockwave-medical-to-participate-in-two-upcoming-virtual-investor-conferences\/","title":{"rendered":"Shockwave Medical to Participate in Two Upcoming Virtual Investor Conferences"},"content":{"rendered":"\n
\n\t
\n\t\t

SANTA CLARA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) \u2014 Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in two upcoming virtual investor conferences.<\/p>\n

The 2021 Virtual Wells Fargo Healthcare Conference
\nFireside Chat on Thursday, September 9, 2021 at 9:20 a.m. Eastern Time.<\/p>\n

The Morgan Stanley 19th Annual Global Healthcare Conference
\nFireside Chat on Monday, September 13, 2021 at 2:45 p.m. Eastern Time.<\/p>\n

About Shockwave Medical, Inc.<\/strong><\/p>\n

Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit\u00a0www.shockwavemedical.com<\/a>.<\/p>\n

Media Contact:
\nScott Shadiow
\n+1.317.432.9210
\nsshadiow@shockwavemedical.com<\/a><\/p>\n

Investor Contact:
\nDebbie Kaster
\ndkaster@shockwavemedical.com<\/a><\/p>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"

Shockwave Medical announced today that the company will be participating in two upcoming virtual investor conferences.<\/p>\n","protected":false},"featured_media":9220,"template":"","format":[],"meta":{"_acf_changed":true,"content-type":""},"disease-state":[],"news-topic":[],"product-tag":[],"specialty":[],"technology":[],"class_list":["post-10256","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/news\/10256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/media\/9220"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/media?parent=10256"}],"wp:term":[{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/disease-state?post=10256"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/format?post=10256"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/news-topic?post=10256"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/product-tag?post=10256"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/specialty?post=10256"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/technology?post=10256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}